Keyword: HIV

News

J&J Ends Mosaico HIV Vaccine Trial on poor Results

27.01.2023 -

Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...

News

Gilead HIV Pill Seen to Lower new Infections

31.10.2018 - An antiviral pill taken daily by thousands of HIV-positive men in Australia has led to a “globally unprecedented” reduction in new infections, according to what is being called...

News

FDA Approves new Two-drug HIV Treatment

29.11.2017 - The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...

News

Abivax and PCAS Collaborate on HIV/Aids Drug

28.04.2016 - French biotechnology company Abivax has signed a contract with API manufacturer PCAS group for the production and supply of ABX464, a drug candidate for treating HIV. Under the...

News

Gilead‘s Genvoya HIV Treatment gets FDA Approval

11.11.2015 - The US Food and Drug Administration (FDA) has approved Gilead Sciences’ Genvoya to treat HIV-1 infection. Genvoya combines four treatments – elvitegravir, cobicistat, emtricitabine...

News

GSK Outlines Pipeline for Next 10 Years

06.11.2015 - GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...

Markets & Companies

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...

News

Bristol-Myers Squibb HIV Drug Fast-Tracked

27.07.2015 - The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...